Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

TAXES ON INCOME (Narrative) (Details)

v3.22.1
TAXES ON INCOME (Narrative) (Details) - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Major Components Of Income Tax Expense [Line Items]    
Applicable tax rate 26.50% 26.50%
Deferred tax assets $ 16 $ 769
Israel [Member]    
Major Components Of Income Tax Expense [Line Items]    
Applicable tax rate 23.00% 23.00%
Carryforward operating tax losses $ 3,153  
Canada [Member]    
Major Components Of Income Tax Expense [Line Items]    
Applicable tax rate 26.50% 26.50%
Carryforward operating tax losses $ 54,218  
Deferred tax assets $ 1,542  
Adjupharm GmbH ("Adjupharm") [Member]    
Major Components Of Income Tax Expense [Line Items]    
Applicable tax rate 29.10%  
Adjupharm GmbH ("Adjupharm") [Member] | German [Member]    
Major Components Of Income Tax Expense [Line Items]    
Carryforward operating tax losses $ 8,964  
Description of carryforward losses for tax purposes Accumulated tax losses can be carried forward without time restrictions and can be deducted from future profits and capital gains unless they exceed €1,000 thousand (approximately $1,441). Any excess of such amount will be limited to 60% of the profits or capital gains